Nearly 90% of the 1,016 U.S. adults surveyed between May 11, 2020, and May 22, 2020, said they are “very” (55%) or “somewhat” (33%) concerned that the pharmaceutical industry will leverage the ongoing pandemic to raise drug prices. According to a news release, Democrats (66%) were more likely to say they are concerned than independents (52%) and Republicans (49%).
Other concerns raised include, to a lesser extent, rising health insurance premiums and the general cost of care, with 79% of those surveyed saying they are very or somewhat concerned about their premiums. Additionally, 84% said they are very or somewhat concerned about the cost of care generally rising and 41% are very concerned about each.
Nearly half (48%) of women polled were very concerned about the general cost of care rising, while 33% of men were in the same bracket. Additionally, 50% of non-whites are very concerned, compared to 36% of whites. About 88% of those polled support direct negotiations by the federal government with a drug manufacturer on the price of treatment for the disease itself.
Gallup and West Health concluded that, with 14% of Americans refusing to seek treatment for COVID-19 symptoms because of the cost of care, leaders may consider policy decisions designed to curtail the possibilities of raised costs, easing the fears of the public.
Tell Us What You Think!